Compounds > terazosin
Page last updated: 2024-11-04

terazosin and Carcinoma, Transitional Cell

terazosin has been researched along with Carcinoma, Transitional Cell in 1 studies

Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tahmatzopoulos, A1
Lagrange, CA1
Zeng, L1
Mitchell, BL1
Conner, WT1
Kyprianou, N1

Other Studies

1 other study available for terazosin and Carcinoma, Transitional Cell

ArticleYear
Effect of terazosin on tissue vascularity and apoptosis in transitional cell carcinoma of bladder.
    Urology, 2005, Volume: 65, Issue:5

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Carcinoma,

2005